The Latest Breaking News from US Federal Reserve

Gold and silver appear to absorb massive tax refund dollars while creating higher prices. In comparison, these metals shine due to the outlook for a possible Federal Reserve Board (Fed) pivot in interest rates. Is Dr. Copper's lagging performance due to the upcoming recession?

Another round of data out of the US is pointing towards inflation there easing, which could mean the Federal Reserve is done with rate hikes, at least for now, and the ASX followed the optimism.

Jeremy Grantham predicted the financial crisis in 2008. Now, he thinks the financial system could expect more chaos after the two banks failed in March.

The Fed’s economists expect a “mild recession” this year, but Goldman’s Jan Hatzius says the cooling labor market means a “soft landing” is still possible.

With the Fed’s minutes revealing an increased risk of recession in the wake of a banking crisis, the retail sales data due tomorrow is also expected to telegraph softening consumer demand in a sluggish economy. Hence, I evaluated the fundamentals of three retail stocks, Torrid Holdings (CURV), The Aaron's Company…

Although inflation has shown signs of easing, it remains elevated. Therefore, the possibility of further rate hikes remains. As fears of a recession rise, investors may consider buying fundamentally strong stocks NetScout Systems (NTCT), Central Puerto (CEPU), and Vanda Pharmaceuticals (VNDA), trading at discounts to their peers. Keep reading….

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.24%. U.S. stock indexes this morning are moderately higher after...

The Federal Reserve’s interest rate hikes since last year showed results as annual inflation dropped for the ninth consecutive month in March. However, with the Fed likely to hike the interest rate at the policy meeting next month, the risk of a recession looms. In this scenario, it could be…

Macroeconomic headwinds-induced volatility and the associated recessionary fears are anticipated to linger for a while, even though inflation is cooling down. Given this backdrop, the strong fundamentals of mid-cap stock Jazz Pharmaceuticals (JAZZ) might make it a solid buy. In contrast, fundamentally weak mid-cap stocks Valvoline (VVV) and Axos Financial…